Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
132.61
Dollar change
+4.74
Percentage change
3.71
%
IndexS&P 500 P/E27.13 EPS (ttm)4.89 Insider Own0.13% Shs Outstand205.60M Perf Week4.81%
Market Cap27.20B Forward P/E15.26 EPS next Y8.69 Insider Trans-8.49% Shs Float204.81M Perf Month4.94%
Income1.02B PEG3.91 EPS next Q1.88 Inst Own91.05% Short Float2.24% Perf Quarter9.22%
Sales7.39B P/S3.68 EPS this Y6.80% Inst Trans-0.06% Short Ratio2.98 Perf Half Y17.92%
Book/sh60.70 P/B2.18 EPS next Y7.77% ROA4.81% Short Interest4.59M Perf Year5.25%
Cash/sh2.03 P/C65.41 EPS next 5Y6.93% ROE8.36% 52W Range102.00 - 149.25 Perf YTD8.96%
Dividend Est.0.85 (0.64%) P/FCF27.78 EPS past 5Y- ROI5.84% 52W High-11.15% Beta1.02
Dividend TTM1.20 (0.90%) Quick Ratio0.78 Sales past 5Y-1.20% Gross Margin63.02% 52W Low30.01% ATR (14)2.07
Dividend Ex-DateMar 27, 2024 Current Ratio1.61 EPS Y/Y TTM344.85% Oper. Margin18.67% RSI (14)70.76 Volatility1.39% 1.49%
Employees18000 Debt/Eq0.48 Sales Y/Y TTM6.55% Profit Margin13.85% Recom2.57 Target Price136.03
Option/ShortYes / Yes LT Debt/Eq0.40 EPS Q/Q423.09% Payout19.66% Rel Volume1.18 Prev Close127.87
Sales Surprise0.61% EPS Surprise2.15% Sales Q/Q6.30% EarningsFeb 08 BMO Avg Volume1.54M Price132.61
SMA205.01% SMA505.91% SMA2008.17% Trades Volume1,806,704 Change3.71%
Date Action Analyst Rating Change Price Target Change
Jan-04-24Downgrade Evercore ISI Outperform → In-line $135 → $125
Oct-20-23Initiated ROTH MKM Neutral $120
Aug-28-23Upgrade BTIG Research Neutral → Buy $139
May-03-23Upgrade BofA Securities Underperform → Neutral
Apr-11-23Upgrade Evercore ISI In-line → Outperform $135 → $148
Mar-31-23Upgrade Jefferies Underperform → Hold $115 → $130
Mar-29-23Initiated UBS Sell $112
Mar-10-23Upgrade Piper Sandler Neutral → Overweight $135 → $145
Jan-09-23Upgrade RBC Capital Mkts Sector Perform → Outperform $125 → $141
Jan-05-23Upgrade Raymond James Mkt Perform → Outperform $144
Mar-27-24 12:23PM
Mar-13-24 04:30PM
Mar-11-24 08:25AM
Mar-08-24 11:29PM
Feb-29-24 09:40AM
07:30AM Loading…
Feb-22-24 07:30AM
05:25AM
Feb-21-24 07:35PM
07:17AM
07:00AM
Feb-18-24 01:26PM
Feb-15-24 06:09AM
Feb-14-24 06:10AM
Feb-12-24 09:40AM
07:30AM
07:00AM Loading…
07:00AM
Feb-08-24 02:24PM
10:08AM
09:30AM
08:21AM
07:40AM
06:54AM
06:41AM
06:39AM
06:30AM
06:09AM
06:09AM
Feb-05-24 09:16AM
Jan-23-24 06:13AM
Jan-22-24 10:42AM
07:30AM Loading…
Jan-16-24 07:30AM
Jan-10-24 12:00AM
Jan-05-24 07:30AM
Dec-28-23 10:49AM
Dec-27-23 07:50PM
Dec-19-23 07:30AM
05:00AM
Dec-15-23 07:18AM
Dec-14-23 07:00AM
Dec-07-23 11:31AM
Nov-29-23 11:34AM
Nov-24-23 09:50AM
Nov-22-23 09:43PM
Nov-21-23 08:52AM
Nov-16-23 07:30AM
Nov-13-23 02:28PM
Nov-08-23 05:44PM
Nov-07-23 01:37PM
10:49AM
09:30AM
07:40AM
07:20AM
07:16AM
06:55AM
06:45AM
06:38AM
06:30AM
Nov-06-23 09:51AM
Nov-05-23 11:17PM
Nov-02-23 11:45AM
09:21AM
Oct-31-23 10:01AM
Oct-30-23 11:31AM
09:00AM
Oct-26-23 11:52AM
Oct-25-23 11:40AM
Oct-20-23 09:37AM
08:45AM
Oct-18-23 12:06PM
Oct-13-23 07:57AM
Oct-12-23 01:52PM
08:14AM
Oct-11-23 11:37AM
Oct-10-23 07:00AM
Oct-05-23 03:28PM
Sep-29-23 12:20PM
08:32AM
Sep-26-23 07:34PM
Sep-14-23 09:40AM
Sep-06-23 04:07PM
11:33AM
Sep-05-23 04:30PM
10:38AM
Sep-03-23 10:30AM
Aug-30-23 09:32AM
Aug-28-23 09:58AM
02:39AM
Aug-27-23 01:54PM
Aug-25-23 05:00PM
Aug-23-23 07:30AM
Aug-22-23 07:38PM
11:38AM
08:20AM
Aug-15-23 10:56AM
Aug-12-23 11:05AM
Aug-07-23 10:51AM
Aug-03-23 11:03AM
06:32AM
Aug-02-23 03:50PM
Aug-01-23 10:44AM
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Yi SangGroup President, Asia PacificMar 07 '24Option Exercise91.531,705156,05919,884Mar 08 05:03 PM
Yi SangGroup President, Asia PacificMar 07 '24Sale126.861,705216,29618,179Mar 08 05:03 PM
Upadhyay SuketuExec. VP, CFOMar 06 '24Option Exercise0.004,561022,683Mar 08 05:05 PM
VAN ZUILEN WILFREDGroup Pres, EMEAMar 06 '24Option Exercise0.002,16307,427Mar 08 05:05 PM
Winkler LoriSVP and CHROMar 06 '24Option Exercise0.001,75703,207Mar 08 05:05 PM
Bezjak MarkPresident, AmericasMar 06 '24Option Exercise0.001,62204,753Mar 08 05:03 PM
Ellingson RachelSVP & Chief Strategy OfficerMar 06 '24Option Exercise0.001,41907,291Mar 08 05:03 PM
Phipps Chad FSr. VP/Gen Counsel/SecretaryMar 06 '24Option Exercise0.002,095050,046Mar 08 05:03 PM
Stellato Paul AVP, Controller & CAOMar 06 '24Option Exercise0.0060901,176Mar 08 05:04 PM
Tornos IvanPresident & CEOMar 06 '24Option Exercise0.0010,270032,395Mar 08 05:04 PM
Yi SangGroup President, Asia PacificMar 06 '24Option Exercise0.002,365018,179Mar 08 05:03 PM
Winkler LoriSVP and CHROMar 02 '24Option Exercise0.0018601,496Mar 05 04:58 PM
Yi SangGroup President, Asia PacificMar 01 '24Option Exercise0.002,052015,814Mar 05 04:59 PM
Phipps Chad FSr. VP/Gen Counsel/SecretaryMar 01 '24Option Exercise0.001,641048,597Mar 05 05:02 PM
Phipps Chad FSr. VP/Gen Counsel/SecretaryFeb 25 '24Option Exercise0.004,580048,725Feb 27 08:57 PM
Tornos IvanPresident & CEOFeb 25 '24Option Exercise0.007,513025,153Feb 27 08:58 PM
Upadhyay SuketuExec. VP, CFOFeb 25 '24Option Exercise0.007,043020,213Feb 27 08:58 PM
Bezjak MarkPresident, AmericasFeb 25 '24Option Exercise0.001,52803,535Feb 27 08:56 PM
Winkler LoriSVP and CHROFeb 25 '24Option Exercise0.001,29401,661Feb 27 08:56 PM
Ellingson RachelSVP & Chief Strategy OfficerFeb 25 '24Option Exercise0.001,76206,460Feb 27 08:57 PM
Yi SangGroup President, Asia PacificFeb 25 '24Option Exercise0.005,047013,762Feb 27 08:55 PM
Phipps Chad FSr. VP/Gen Counsel/SecretaryFeb 22 '24Option Exercise91.5326,1562,394,05970,301Feb 26 06:02 PM
Phipps Chad FSr. VP/Gen Counsel/SecretaryFeb 22 '24Sale128.6226,1563,364,12644,145Feb 26 06:02 PM
Jafry Syed A.DirectorNov 09 '23Buy104.752,135223,6414,060Nov 13 04:02 PM
Kolli SreelakshmiDirectorAug 30 '23Buy120.371,000120,3701,000Sep 01 04:01 PM
HAGEMANN ROBERTDirectorAug 28 '23Buy116.482,000232,9604,000Aug 30 04:03 PM
BEGLEY CHRISTOPHER BDirectorAug 28 '23Buy117.111,000117,1143,540Sep 29 04:05 PM
MICHELSON MICHAEL WDirectorAug 25 '23Buy115.501,300150,1503,385Aug 29 06:57 PM
BERNARD BETSY JDirectorAug 25 '23Buy114.84871100,0235,271Aug 29 06:51 PM
HIGGINS ARTHUR JDirectorAug 23 '23Buy115.611,000115,6133,400Aug 25 04:31 PM
VAN ZUILEN WILFREDPres, Europe, M. East & AfricaJul 01 '23Option Exercise0.002,63305,073Jul 05 04:07 PM
Upadhyay SuketuExec. VP, CFOJul 01 '23Option Exercise0.003,768014,660Jul 05 04:10 PM
Stellato Paul AVP, Controller & CAOJun 01 '23Option Exercise0.006280678Jun 05 04:03 PM